We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.85%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$25.7B
AUM Growth
-$62.8M
(-0.24%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-0.47%
Top 10 Holdings %
Top 10 Hldgs %
18.43%
Holding
1,885
New
196
Increased
495
Reduced
475
Closed
173
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cintas
CTAS
|
+$191M |
| 2 |
Salesforce
CRM
|
+$110M |
| 3 |
Zoetis
ZTS
|
+$105M |
| 4 |
Union Pacific
UNP
|
+$101M |
| 5 |
IBM
IBM
|
+$93.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$252M |
| 2 |
Campbell Soup
CPB
|
+$155M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$116M |
| 4 |
Comcast
CMCSA
|
+$102M |
| 5 |
RTN
Raytheon Company
RTN
|
+$98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.27% |
| 2 | Technology | 14.3% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Healthcare | 11.66% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Selective Insurance
SIGI
$5.53B
| $2.33M | 0.01% |
38,300
-900
| -2% | -$53.1K |
|
352
Helmerich & Payne
HP
$3.36B
| $2.32M | 0.01% |
34,846
+3,459
| +11% | +$233K |
|
353
MidCap Financial Investment
MFIC
$790M
| $2.31M | 0.01% |
147,611
| – | – |
|
354
ICU Medical
ICUI
$4.04B
| $2.3M | 0.01% |
9,100
-1,100
| -11% | -$259K |
|
355
Idexx Laboratories
IDXX
$43.9B
| $2.29M | 0.01% |
11,982
+437
| +4% | +$80.7K |
|
356
Haemonetics
HAE
$3.63B
| $2.29M | 0.01% |
31,300
-6,700
| -18% | -$460K |
|
357
Tetra Tech
TTEK
$8.28B
| $2.29M | 0.01% |
233,550
-12,000
| -5% | -$119K |
|
358
Invesco Advantage Municipal Income Trust II
VKI
$396M
| $2.28M | 0.01% |
215,160
-500
| -0.2% | -$5.47K |
|
359
Gartner
IT
$9.87B
| $2.28M | 0.01% |
19,394
+2,896
| +18% | +$362K |
|
360
Churchill Downs
CHDN
$6.15B
| $2.28M | 0.01% |
55,998
-7,800
| -12% | -$332K |
|
361
iShares National Muni Bond ETF
MUB
$45.2B
| $2.27M | 0.01% |
20,837
+12,503
| +150% | +$1.36M |
|
|
ALE
362
DELISTED
Allete
ALE
| $2.23M | 0.01% |
30,900
| – | – |
|
363
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.66B
| $2.22M | 0.01% |
153,000
| – | – |
|
364
H&R Block
HRB
$5.37B
| $2.22M | 0.01% |
87,256
-5,664
| -6% | -$149K |
|
|
CLR
365
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $2.19M | 0.01% |
37,109
-49
| -0.1% | -$2.64K |
|
366
Integra LifeSciences
IART
$1.52B
| $2.19M | 0.01% |
39,500
-100
| -0.3% | -$5.24K |
|
367
Wintrust Financial
WTFC
$10.7B
| $2.18M | 0.01% |
25,300
| – | – |
|
|
VVC
368
DELISTED
Vectren Corporation
VVC
| $2.17M | 0.01% |
33,951
-185
| -0.5% | -$11.4K |
|
369
Medtronic
MDT
$108B
| $2.17M | 0.01% |
27,046
+5,868
| +28% | +$484K |
|
|
UN
370
DELISTED
Unilever NV New York Registry Shares
UN
| $2.15M | 0.01% |
38,158
+8,792
| +30% | +$483K |
|
|
NFX
371
DELISTED
Newfield Exploration
NFX
| $2.14M | 0.01% |
87,668
-697
| -0.8% | -$19.5K |
|
372
Mine Safety
MSA
$6.78B
| $2.11M | 0.01% |
25,300
| – | – |
|
373
Insperity
NSP
$1.92B
| $2.1M | 0.01% |
30,200
-1,800
| -6% | -$115K |
|
374
Applied Industrial Technologies
AIT
$12.9B
| $2.09M | 0.01% |
28,700
-1,200
| -4% | -$86.1K |
|
375
Vanguard Dividend Appreciation ETF
VIG
$112B
| $2.09M | 0.01% |
20,681
+1,234
| +6% | +$128K |
|
Similar funds
Bessemer Group's Q1 2018 Portfolio in Review
As of Q1 2018, Bessemer Group held 1,885 positions worth $25.7B, down 0.24% from $25.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bessemer Group's Q1 2018 filing shows 196 new, 495 increased, 475 reduced and 173 closed positions. Its largest new stake was Cintas: 4,607,876 shares worth $197M. The largest sale was Eli Lilly, an estimated $252M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
- Bessemer Group's largest Q1 2018 buy was Cintas: 4,607,876 shares worth $197M.
- Bessemer Group added most to Salesforce in Q1 2018, an estimated $110M increase.
- Bessemer Group's biggest Q1 2018 reduction was Eli Lilly, cutting an estimated $252M.
- Bessemer Group fully exited Validus Hold Ltd in Q1 2018, selling an estimated $19.5M.
- Bessemer Group's ten largest holdings make up 18% of its $25.7B portfolio in Q1 2018.
- Bessemer Group opened 196 new positions and closed 173 in Q1 2018.
- Bessemer Group's portfolio value fell 0.24% quarter-over-quarter to $25.7B.
Based on Bessemer Group's 13F filing for Q1 2018, filed 10 May 2018.